Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Meitu, Inc. (1357.HK)

HKSE - HKSE Delayed Price. Currency in HKD
1.040-0.040 (-3.70%)
At close: 04:08PM HKT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.080
Open1.090
Bid1.030 x 0
Ask1.040 x 0
Day's Range1.020 - 1.140
52 Week Range0.650 - 1.780
Volume55,087,000
Avg. Volume20,350,311
Market Cap4.485B
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateAug 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Bloomberg

    Chinese Beauty App Meitu Slides as Crypto Bets Steepen Losses

    (Bloomberg) -- Shares of Meitu Inc. extended their decline into a fourth day after the beauty-app developer disclosed that it expects first-half losses to widen due to soured cryptocurrency bets. Most Read from BloombergTycoon Whose Bet Broke the Nickel Market Walks Away a BillionaireNatural Gas Soars 700%, Becoming Driving Force in the New Cold WarUS, Allies Discuss Capping Russian Oil at $40-$60 a Barrel to Cut War FinancingRoaring US Rental Market Shows Early Signs of Slowing DownBoris Johnso

  • GlobeNewswire

    Clover Selected for Inclusion on the Hang Seng Composite Index

    CHENGDU, China, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that it has been selected for inclusion in the Hang Seng Composite Index as a constituent stock, effective March 7, 2022. Hang Seng Composite IndexHang Seng Small Cap (Investable) IndexHang Seng Healthcare IndexHang Seng Hong Kong-Listed Biotech IndexHang Seng Stock Con

  • PR Newswire

    Dynavax to Present at the Cowen 42nd Annual Health Care Conference

    Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer, Chief Executive Officer and Kelly MacDonald Chief Financial Officer, will participate in a virtual fireside chat at the Cowen 42nd Annual Health Care Conference on Wednesday, March 9, at 2:50 p.m. E.T.

Advertisement
Advertisement